An elegant study using a mouse model of prostate cancer (PC) has identified IgA+ plasmocytes intratumorally, and shown that this B-cell subset can prevent oxaliplatin-mediated tumor-directed cytotoxic T-cell functions, via the expression of IL-10 and PD-L1 (38). This evidence concerns the gene CD79A and pachyonychia congenita.